CSPC Pharmaceutical Group Limited (HKG:1093)
7.48
-0.10 (-1.32%)
May 19, 2026, 11:59 AM HKT
CSPC Pharmaceutical Group Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of 86.66 billion as of May 18, 2026. Its market cap has increased by 22.98% in one year.
Market Cap
86.66B
Enterprise Value
77.36B
Revenue
28.94B
Ranking
n/a
PE Ratio
20.05
Stock Price
7.48
Market Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 696.00M to 86.66B, an increase of 12,351.51%. That is a compound annual growth rate of 17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 86.66B | -10.08% |
| Dec 31, 2025 | 96.38B | 74.70% |
| Dec 31, 2024 | 55.17B | -35.87% |
| Dec 29, 2023 | 86.02B | -11.96% |
| Dec 30, 2022 | 97.71B | -3.19% |
| Dec 31, 2021 | 100.93B | 6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansoh Pharmaceutical Group Company | 213.17B |
| JD Health International | 145.00B |
| Innovent Biologics | 142.29B |
| WuXi Biologics | 139.36B |
| Akeso | 110.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.81B |
| Sino Biopharmaceutical | 96.18B |
| WuXi XDC Cayman | 69.07B |